48,830
edits
Difference between revisions of "Carbonic anhydrase 9"
Jump to navigation
Jump to search
→Positive: more
(→Positive: more) |
|||
| Line 9: | Line 9: | ||
*[[Malignant mesothelioma|Epithelioid mesothelioma]].<ref name=pmid23503645>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. | journal = Mod Pathol | volume = 26 | issue = 8 | pages = 1132-43 | month = Aug | year = 2013 | doi = 10.1038/modpathol.2013.34 | PMID = 23503645 }}</ref> | *[[Malignant mesothelioma|Epithelioid mesothelioma]].<ref name=pmid23503645>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. | journal = Mod Pathol | volume = 26 | issue = 8 | pages = 1132-43 | month = Aug | year = 2013 | doi = 10.1038/modpathol.2013.34 | PMID = 23503645 }}</ref> | ||
*Benign mesothelium.<ref name=pmid24926090>{{Cite journal | last1 = Ananthanarayanan | first1 = V. | last2 = Tretiakova | first2 = M. | last3 = Husain | first3 = AN. | last4 = Krausz | first4 = T. | last5 = Antic | first5 = T. | title = Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium. | journal = Am J Clin Pathol | volume = 142 | issue = 1 | pages = 82-7 | month = Jul | year = 2014 | doi = 10.1309/AJCP8BJ8CJXUEHZD | PMID = 24926090 }}</ref> | *Benign mesothelium.<ref name=pmid24926090>{{Cite journal | last1 = Ananthanarayanan | first1 = V. | last2 = Tretiakova | first2 = M. | last3 = Husain | first3 = AN. | last4 = Krausz | first4 = T. | last5 = Antic | first5 = T. | title = Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium. | journal = Am J Clin Pathol | volume = 142 | issue = 1 | pages = 82-7 | month = Jul | year = 2014 | doi = 10.1309/AJCP8BJ8CJXUEHZD | PMID = 24926090 }}</ref> | ||
*[[Fibroadenoma]] ~29% of cases.<ref name=pmid23816158>{{Cite journal | last1 = Furjelová | first1 = M. | last2 = Kovalská | first2 = M. | last3 = Jurková | first3 = K. | last4 = Horáček | first4 = J. | last5 = Carbolová | first5 = T. | last6 = Adamkov | first6 = M. | title = Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma. | journal = Acta Histochem | volume = 116 | issue = 1 | pages = 89-93 | month = Jan | year = 2014 | doi = 10.1016/j.acthis.2013.05.009 | PMID = 23816158 }}</ref> | |||
*Breast carcinoma ~62% of cases.<ref name=pmid23816158/> | |||
===Negative=== | ===Negative=== | ||